ArticleJournal of epidemiology and global health2024

Efficacy and Safety of Injectable Dulaglutide 1.5 mg Among Type 2 Diabetes Patients in Clinics at King Saud Medical City, Riyadh, Saudi Arabia.

Mashael Saad Albargawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.